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Abstract
Subject dropout is a vexing problem for any biomedical study, especially when
the dropout subjects dier from the non-dropout subjects in terms of the main
outcome(s). Usual statistical method that intends to correct estimation bias re-
lated to this phenomenon involves unveriable assumptions about the dropout
mechanism. We consider a unique cohort study in Africa that uses an outreach
program to ascertain the mortality information vital status for dropout subjects.
These data can be used to identify a number of relevant distributions. However
only a subset of dropout subjects were followed, vital status ascertainment was
incomplete. We use semi-competing risk methods as our analysis framework to
address this specic case where the terminal event is incompletely ascertained and
consider various procedures for estimating the marginal distribution of dropout
and the marginal and conditional distributions of survival. We also consider
model selection and estimation eciency in our setting. Performance of the pro-
posed methods is demonstrated via simulations, asymptotic study, and analysis
of the study data.
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1 Introduction
Competing risk data are common for time-to-event outcomes (Klein and Moeschberger
1997). In particular, the usual censored failure time data can be viewed as competing
risk data when censoring is regarded as a competing cause of failure. More generally,
study subjects may experience a number of distinct failure types. It is well-known that,
with competing risk data, nonparametric estimation of the marginal and conditional
distributions of the competing outcomes is generally infeasible (Tsiatis 1975).
Semi-competing risk data are related to two types of events, a terminal event and
a non-terminal event, where a terminal event such as death is always observed but
the non-terminal event (such as disease progression or treatment interruption) may be
censored by the terminal event. Semi-competing risk data are therefore an enriched
form of competing risk data in the sense that the non-terminal event is not a competing
cause of the terminal event but not vice versa. This special structure allows estimation
of the marginal distribution of the terminal event. Using copula models for the joint
distribution of the two types of events, the marginal distribution of the non-terminal
event can also be identied, and the correlation between the two events can be modeled
explicitly (Fine, Jiang, Chappell 2011, Wang 2003, Lakhal, Rivest, Abdous 2008).
Semi-competing risk data are frequently encountered. A typical example is the
illness-death situation (Fix and Neyman 1951, Sverdrup 1965, Xu, Kalbeisch, and
Tai 2010), where death can censor the observation of illness if it occurs prior to illness,
but occurrence of the illness may not prevent further follow-up on death. There are
other semi-competing risk examples that do not t into the illness-death framework. In
AIDS studies, for example, time to rst virologic failure and treatment discontinuation
can be considered as the non-terminal and terminal events respectively (Jiang, Fine,
Kosorok, and Chappell 2005). In oncology, they can be times to local and distant
recurrences respectively (Dignam, Wieand, Rathouz 2007). Other interesting examples
exist in biomarker studies (Ghosh 2009, Day, Bryant, and Lefkopolou 1997).
In this article, we consider the case when it is dicult or infeasible to ascertain all
terminal events, especially in large cohort studies. This is the case of our motivating
example, a cohort study of 8,977 adults who were enrolled between January 1, 2005 and
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January 31, 2007 in the Academic Model Providing Access To Healthcare (AMPATH)
program (Mamlin, Kimaiyo, Nyandiko, et al. 2004). AMPATH, the Nobel Peace Prize-
nominated HIV care and treatment program, is a partnership between the Indiana
University and Moi University Schools of Medicine in western Kenya. A key component
in the evaluation of the eectiveness of this program is the marginal survival as well
as the conditional survival (on being retained in care) distributions for patients under
care. However, estimation of the distributions are severely complicated by the fact that
there is a very high rate of patient loss to follow-up (Wools-Kaloustian et al., 2008).
Moreover, there was evidence that the individuals lost to follow-up were generally sicker
than those who remained on observation (An, Frangakis, Musick, and Yiannoutsos
2008, Yiannoutsos, An, Frangakis et al. 2008). These factors have the potential of
introducing a signicant bias if estimation is based only on data derived from patients
under care.
Fortunately, AMPATH has instituted a major campaign to locate as many of the
patients who are lost to follow-up as possible. The AMPATH patient outreach pro-
gram uses location information available on all patients in an eort to ascertain the
whereabouts of missing patients and attempt to persuade them to return to care. In
the process, the program records, among other information, the vital status of all
patients sought and successfully located. Using outreach data and theory on double
sampling (Frangakis and Rubin 2001), estimation of the marginal survival distribution
is possible (An et al. 2008). In this article, by viewing dropout as the non-terminal
event and death as the terminal event, we revisit this estimation and consider more
ecient estimators within the semi-competing risk data framework. In addition, we
consider estimation of the conditional survival distributions and of the marginal dis-
tributions of the dropout in rural and urban areas that is informative for future policy
making in providing care. Note that our considerations are applicable to the usual
semi-competing risk situation (i.e. with 100% outreach), which is a special case of our
setting.
The rest of the article is organized as follows. In Section 2 we consider estimation
for the dependency between the terminal and non-terminal events using copula mod-
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els. In Section 3 we discuss estimation of marginal distributions for non-terminal and
terminal events. In particular, we investigate how to improve the eciency of marginal
distribution estimation for the terminal event by using the non-terminal event infor-
mation. In Section 4, we consider estimation of the conditional survival distribution
for the terminal event, conditioning on the non-terminal event. In Section 5, we con-
sider model selection among possible models. In Section 6 we assess the performance
of our revised copula estimators through simulations, using realistic parameters from
our experience in this setting and perform a reanalysis of the AMPATH database (An
et al. 2008 and Yiannoutsos et al. 2008). We conclude with a brief discussion of the
implications of this methodological development in Section 7.
2 Modeling the dependency between X and Y
Let X be the time to the non-terminal event, Y the time to the terminal event, and C
the administrative censoring time. In semi-competing risk data, X can be censored by
Y if Y < X, but is observable if Y  X. However both X and Y can be censored by C.
Therefore the observable quantities are: R = Y ^C, R = 1(Y < C), S = X ^Y ^C =
X ^ R, and S = 1(X < R) where ^ is the minimum operator. Now suppose that,
among all subjects with S = 1, we only observe R in a subset. Therefore, we have
an indicator variable  for each subject such that R is only observed if  = 1. We
assume that  , P ( = 1) = Sp+ (1  S) where p is the proportion of dropouts who
have been successfully located. Our objective is to estimate the marginal distributions
FX(x) = P (X > x) and FY (y) = P (Y > y), and the conditional survival distributions
such as P (Y > yjX = x; Y > t) and P (Y > yjX > x; Y > t) for y > t > x.
We assume the following copula model for the joint survival distribution of X and
Y (Oakes 1989):
F (x; y) = P (X > x; Y > y) = CfFX(x); FY (y)g
We are particularly interested in a class of copulas indexed by a single parameter . A
possible choice for C is the well known Archimedean copula with generator  (Fine
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et al. 2001, Wang 2003),
C(u; v) = 
 1
 f(u) + (v)g; 0  u; v  1
Popular choices of  include the Clayton copula (Clayton 1978): (t) = t
1  1 and
the Gumbel copula: (t) = (  log t),   1.
A quantity which is useful in the eort to explicitly model the dependency between
the terminal and non-terminal event is the cross-ratio function (Oakes 1989):
(x; y) =
Pf(Xi  Xj)(Yi   Yj) > 0jXi ^Xj = x; Yi ^ Yj = yg
Pf(Xi  Xj)(Yi   Yj) < 0jXi ^Xj = x; Yi ^ Yj = yg : (1)
This function is related to Kendall's tau (Wang 2003, Lakhal et al. 2008). Under
the Archimedean copulas,  depends on x and y only through their joint survival
distribution F (x; y) and takes the form
(x; y) =  F (x; y)
00(F (x; y))
0(F (x; y))
, (F (x; y)); (2)
where (v) =  v00(v)=0(v) for any v.
Utilizing (2), Lakhal et al. (2008) proposed the following estimating equation for
general Archimedean copulas:
	n() =

n
2
 1X
i<j
W ( ~Sij; ~Rij)Zij

ij   fF^ (
~Sij; ~Rij)g
1 + fF^ ( ~Sij; ~Rij)g

(3)
where ~Sij = Si^Sj, ~Rij = Ri^Rj, and ~Cij = Ci^Cj; ij = 1f(Si Sj)(Ri Rj) > 0g;
Zij = 1( ~Sij < ~Rij < ~Cij); and W is a weighting function. Because
F (x; y) =
P (S > x;R > y)
P (C > y)
; (4)
F (x; y) is estimated by
F^ (x; y) =
n 1
Pn
i=1 1(Si > x;Ri > y)
G^(y)
with
G^(y) =
Y
i:Ciy

1  1 RiPn
k=1 1(Rk  y)

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being the Kaplan-Meier estimator for the censoring distribution. Zij is needed in (3)
because ij is evaluable only when Zij = 1 (Lakhal et al. 2008, Fine et al. 2001)
and in this case ij equals the concordance between (Xi; Yi) and (Xj; Yj), that is,
1f(Xi  Xj)(Yi   Yj) > 0g. The weighting function may be taken as 1 but a preferred
form is given by (Fine et al. 2001)
Wa;b(x; y) =
nPn
i=1 1fSi  a ^ x;Ri  b ^ yg
(5)
where a and b are constants and may be selected to down weight for `large' x and y.
In our case, because for subjects with Si < Ri, Ri is observable only when i = 1,
we propose the following estimating function when double sampling data are available:
	n() =

n
2
 1X
i<j
ij
ij
W ( ~Sij; ~Rij)Zij

ij   fF^
( ~Xij; ~Yij)g
1 + fF^ ( ~Xij; ~Yij)g

: (6)
We can take the weighting function W  as 1, or corresponding to (5), use
W a;b(x; y) =
nPn
i=1
i
i
1fSi  a ^ x;Ri  b ^ yg (7)
F^ (x; y) estimates F (x; y) and again take the following form because of (4),
F^ (x; y) =
P^ (S > x;R > y)
P^ (C > y)
(8)
When double sampled data are available, various estimators can be used for the nu-
merator and denominator in (8). For P^ (S > x;R > y), we can use
P^ ;1(S > x;R > y) = n 1
nX
i=1
i
i
1(Si > x;Ri > y) (9)
which inversely weighs the observations because of double sampling. However, an
alternative choice is
P^ ;2(S > x;R > y) = n 1
nX
i=1
n
1(Si > y) +
i
i
1(Si > x; Si <= y;Ri > y)
o
(10)
where inverse weighting is only used for the subjects that need double sampling to
ascertain the indicator 1(Si > x;Ri > y). Because (10) utilizes more information, we
use it in this article.
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There are also two choices to estimate the censoring distribution in (8) under the
double sampled data. One is
G^(y) =
Y
i:Ciy

1  i
i
1 RiPn
k=1
k
k
1(Rk  y)

;
which utilizes inverse weighting. The other is
~G(y) =
Y
i:Ciy

1  (1 Si)(1 Ri)Pn
k=1 1(Sk  y)

:
which uses X ^Y as a censoring variable for C and does not involve inverse weighting.
We use ~G(y) in (8) because greater eciency gains were observed in simulations.
By recognizing that the weighted estimator is related to U-statistics, we derive
the asymptotic properties of the resulting estimator ^ from (6) in the Appendix.
Because the asymptotic variance is complicated, we use a bootstrap procedure to obtain
standard error estimates as in Lakhal et al (2008).
Finally, we note that for the Clayton copula,  =  is not related to either x or y
and P (ij = 1) =

1+
for any i 6= j (Oakes 1989, Fine et al. 2001). Then it is easily
seen that an explicit solution for  exists from (3):
^ =
P
i<j
ij
ij
W ( ~Sij; ~Rij)ZijijP
i<j
ij
ij
W ( ~Sij; ~Rij)Zij(1 ij)
:
When   1 in the semi-competing risk data, this reduces to the estimator from Fine
et al. (2001).
3 Estimation of marginal distributions
3.1 Estimation of the marginal survival distribution of Y
Adopting the counting process notation (Kalbeisch and Prentice 2002), we estimate
the cumulative hazard function of Y by
^;1Y (t) =
Z t
0
Pn
i=1(1  Si)dNi(u) +
Pn
i=1
i
i
SidNi(u)Pn
i=1(1  Si)1(Ri  u) +
Pn
i=1
i
i
Si1(Ri  u)
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where Ni(u) = 1(Yi  u;Ci > Yi). This estimator was proposed in Frangakis and
Rubin (2001). The corresponding survival function estimate is then
F^ ;1Y (t) = exp
(
 
nX
i=1
^;1Y i (t)
)
: (11)
An alternative way is to estimate the cumulative hazard function of Y by
^;2Y (t) =
Z t
0
Pn
i=1(1  Si)dNi(u) +
Pn
i=1
i
i
SidNi(u)Pn
i=1(1  Si)1(Ri  u) +
Pn
i=1 Si1(Si  u) +
Pn
i=1
i
i
Si1(Si < u)1(Ri  u) :
This estimator has been mentioned in Robins, Rotnitzky, and Bonetti (2001). Notice
that the calculation of the at-risk set at any time u uses the similar idea as in the
estimation of P^ ;2(S > x;R > y) in (10) where inverse weighting is only used for the
subjects that need double sampling to ascertain the at risk status. The corresponding
survival function estimate is then
F^ ;2Y (t) = exp
(
 
nX
i=1
^;2Y i (t)
)
: (12)
Asymptotics for both (11) and (12) can also be established in a similar fashion as in
Yu and Nan (2010).
Neither approach utilizes the correlation between X and Y . We therefore consider
a model-based estimator. In particular, by partitioning P (Y > t) as
P (Y > t) = P (Y ^ C > t) + P (Y > t; C  t;X < C) + P (Y > t; C  t;X > C);
we propose the following estimate
F^ ;MY (t) =
1
n
nX
i=1
1(Ri > t)

(1  Si) + i
i
Si
	
+
1
n
nX
i=1
1(Ri  t)(1  Ri)i
i
SiP^ (Y > tjX = Si; Y > Ri) (13)
+
1
n
nX
i=1
1(Ri  t)(1  Ri)(1  Si)P^ (Y > tjX > Si; Y > Si):
Here the P^ (Y > tjX = Si; Y > Ri) and P^ (Y > tjX > Si; Y > Si) are conditional
estimates of the corresponding probabilities. The estimates will be discussed in Section
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4. To avoid a circular problem, we use F^ ;2Y in estimation of these conditional distri-
butions (see Section 4) because F^ ;2Y is generally more ecient than F^
;1
Y (see Figure
1).
As we demonstrate in our numerical section, compared to (11) and (12), F^ ;MY (t)
improves eciency noticeably when there is moderate to high correlation between X
and Y . Such improvement is important especially when a large number of subjects
experience X and double sampling for Y is costly (i.e., p is small).
3.2 Estimation of the marginal distribution of X
We adapt the copula graphic (CG) estimator for the marginal distribution FX(x) from
Lakhal et al. (2008) in our double sampled data. The CG estimator utilizes the
following relationship (Zheng & Klein 1995):
FX(x) = 
 1
 f[F (x; x)]  [FY (x)]g
where F (x; x) = P (X ^ Y > x) , FX^Y (x) and FY is the marginal distribution of Y .
By replacing unknown parameters with estimates, the resulting CG estimator is
F^CGX (x) = 
 1
^
n X
Six;Si=1
^[F^X^Y (Si)]  ^[F^X^Y (Si )]
o
: (14)
Here F^X^Y is the Kaplan-Meier estimator for X ^ Y which needs no inverse weighting
because observation of X ^ Y is unaected by double sampling. Note that because
FY is discrete and jumps only at observed failure times of Y , the term involving FY
disappears in (14) (Rivest and Wells 2001, Lakhal et al. 2008). The CG estimator is
therefore a discrete function that jumps only at observed failure times of X.
In the presence of double sampling, because Si are always observed and therefore
are used in the same way to estimate F (x; x) and because FY is not involved in (14),
the CG estimator has exactly the same format as in (14), i.e.,
F^ ;CGX (x) = 
 1
^
n X
Six;Si=1
^ [F^X^Y (Si)]  ^ [F^X^Y (Si )]
o
: (15)
The asymptotic distribution of this estimator is therefore exactly the same as in the
complete ascertainment case, except that we replace ^ with ^ given as a solution of
(6), taking into consideration the asymptotic normality of ^ from the Appendix.
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4 Estimation of Conditional Distributions
The conditional survival function of a patient that has not dropped out at time x
is P (Y > yjX > x;Y > x). Note here that the ability to evaluate this conditional
probability is particularly relevant in our context, since it is useful in directly addressing
the question of what the survival distribution is for a patient who is retained in care
up to time x > x, where x is a clinically meaningful threshold (e.g., three or six
months from start of antiretroviral therapy, a critical period in the care and treatment
of HIV-infected patients initiating therapy).
Just like in the estimation of the marginal distribution of Y , two dierent estimators
can be used for P (Y > yjX > x;Y > x) = F (x; y)=F (x; x). One is nonparametric:
P^ (Y > yjX > x;Y > x) = F^
(x; y)
F^X^Y (x)
where F^  is dened in (8). The other is model based:
P^M(Y > yjX > x;Y > x) = C^fF^
;CG
X (x); F^
;2
Y (y)g
C^fF^ ;CGX (x); F^ ;2Y (x)g
(16)
with F^ ;CG from (15) and F^ ;2Y from (12). Of course F^
;1
Y from (11) can also be used
in (16) with some loss of eciency.
The conditional survival function of a patient who drops out at time x and is alive
at x is P (Y > yjX = x;Y > x) for y > x. It satises (Lakhal et al. 2008)
P (Y > yjX = x;Y > x) = 
0
fF (x; x)g
0fF (x; y)g
=
0fFX^Y (x)g
0fF (x; y)g
:
with 0(t) the derivative of (t) with respect to t. We can then obtain an estimator by
plugging in estimators for , FX^Y (x), and F (x; y). Similar to estimation of P^M(Y >
yjX > x;Y > x), we can use a nonparametric estimator,
P^ (Y > yjX = x;Y > x) = 
0
^

F^ (x; y)

0^

F^X^Y (x)

or a model based estimator,
P^M(Y > yjX = x;Y > x) = 
0
^

C^fF^ ;CGX (x); F^ ;2Y (y)g

0^

C^fF^ ;CGX (x); F^ ;2Y (x)g
 (17)
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The performance of all these semi-parametric estimators of the conditional survival
distributions is explored through simulations.
5 Model selection
The idea is to choose a quantity that is both estimable by the data (nonparametrically)
and by the proposed models. Among the proposed models, the model which produces
the closest estimate to the quantity is deemed the best. Such quantity should not be
used already in the estimating procedure and sensitive to dierent models. One such
quantity is F (x; y; S=R=1) , P (X > x; Y > y;S = 1;R = 1), which is estimable
nonparametricly by
F^ (x; y; S=R=1) , n 1
nX
i=1
i
i
1(Si > x;Ri > y;Si = 1;Ri = 1):
Under an Archimedean copula model,
F (x; y; S=R=1) =
Z 1
y

0

FY (t)

fY (t)
0

F (x; t)
   0FY (t)fY (t)
0

F (t; t)
 G(t)dt
Therefore it can also be estimated by
~F (x; y; S=R=1) =
Z 1
y

0^

F^ ;2Y (t)

0^

F^ (x; t)
   0^F^ ;2Y (t)
0^

F^ (t; t)
G^(t)dF^ ;2Y (t)
The maximum distance, D , max0<x<yjF^ (x; y; S = R=1)   ~F (x; y; S = R=1)j
is then used as a criterion to choose dierent models. In other words, among possible
AC models, the model with the smallest dierence measure D is chosen. This builds
on the model checking method of Hsieh, Wang and Adam (2008).
Of course, it is likely that no model among the proposed ones provides adequate t
to the data. In this case, calibration by p-values may be desirable for model selection
purposes (Hsieh et al. 2008). A similar bootstrap approach will be taken to approx-
imate the null distribution of the dierence measure. Specically, bootstrap samples
of (X; Y ) will be generated from the estimated copula model and C from G^. The
bootstrap samples will then be censored according to semi-competing risk framework.
The model tting measures are then calculated for all the bootstrap samples to create
the null distribution.
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6 Numerical examples
In this section we assess the performance of various proposed estimators and the model
selection procedure. We also analyze the data from the AMPATH study.
6.1 Simulations
In generating data, the marginal distribution of Y is taken to be unit exponential
and the marginal distribution of X exponential with rate 0.8. This leads to about
40 percent dropout. This is close to the rate of 39.3% reported in An, Yiannoutsos,
Frangakis et al. (2008). The censoring distribution is uniform within the interval (0; 4).
To save space, we present results using the Clayton and Gumbel copulae with various
 for the correlation between X and Y . We used the bootstrap procedure for standard
error estimation in all analyses.
In the following sections, we present results for estimation of the correlation between
X and Y in Table 1; for the marginal distributions of X and Y in Table 2; and for
the conditional distributions of Y given X in Table 3. A total of 400 data sets were
simulated in each scenario with various correlations between X and Y . The sample
sizes were set to be 1000 and 3000 in each setting. The double sampling proportion is
set to be 0:2.
In Table 1, we see that our estimation procedure performs satisfactorily in all cases.
The standard error decreases with larger sample size n = 3000 as compared with
n = 1000. In Table 2, we try to estimate the marginal distribution of X at one year
(i.e., t = 1) and the marginal distribution of Y at 2 years (t = 2). The CG estimates
are all close to the true value exp( 1) = 0:368 and the estimates for FY (2) are all
close to the true value exp( 0:8  2) = 0:202. Among the standard error estimates of
the three estimators of FY , we see that F^
;1
Y is the most inecient and F^
M
Y the most
ecient among the three. The improvement of eciency is actually related to the
strength of correlation between X and Y . Figure 1 illustrates the eciency comparison
among these marginal distribution estimators under the two copulae. Here the x-axis
represents the correlation between X and Y (instead of  values in the copulae). The
results are based on the same setting as in Table 1 but with 50,000 simulated data.
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We see that F^ ;2Y is in general more ecient than F^
;1
Y except in the case of very high
correlations. When the correlation is small, model based estimator can be inecient.
However the eciency improves dramatically as correlation increases. This implies that
the model-based estimator may be preferred if there is moderate to high correlations.
Table 3 gives results for estimation of conditional distributions F1:5j:75 , P (Y >
1:5jX = 0:75; Y > 0:75) and F1:5j:75+ , P (Y > 1:5jX > 0:75; Y > 0:75). Again
the results are satisfactory. Finally, we conducted model selection procedures under
the same setting with results listed in Table 4. We can see that correct models were
selected with very high percentage in all cases. The correct selection percentages are
higher with the larger sample size as expected.
6.2 The AMPATH study
The study included 8,977 adults coming from both urban and rural clinics in western
Kenya between January 1, 2005 and January 31, 2007. There is a very high rate of
patient loss to follow-up (3,528 dropouts). In the outreach program, 621 were double
sampled for further follow-up. The initial goal of AMPATH was to establish an HIV
care system to serve the needs of both urban and rural patients and to assess the
barriers to and outcomes of antiretroviral therapy. It is important to explore dierences
in dropout patterns and patient survival between the rural and urban areas. For the
urban area, there were 6561 subjects among whom 38% dropped out. The outreach
rate is 18%. The maximum follow up is 761 days with a total of 136 deaths observed.
For the rural area, there were 2416 subjects among whom 43% dropped out. The
outreach rate is 23%. The maximum follow up is 761 days with a total of 86 deaths
observed.
The analysis results listed in Table 5 are based on the Clayton copula which was
selected based on the dierence measure proposed in Section 5. The marginal distribu-
tions for dropout and survival in rural and urban clinics are plotted in Figure 2. The
conditional survival distributions in rural and urban clinics are plotted in Figure 3.
In Table 5, the estimate of the  index of the Clayton copula (s.e.) was 2.865
(0.481) among patients enrolled in the urban clinic and 1.852 (0.419) for rural clinics.
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These estimates correspond to correlations of 0.59 and 0.48, which in turn suggests
that patient dropout is non-ignorable. We can also see that the rural clinics appear to
have inferior outcomes in several aspects (Table 5). Among the statistical signicant
dierences, the non-dropout rate at 1 year is 59.8% compared with 62.4% in the urban
area. Patients retained in care for 3 or 6 months, also have shorter survival when at-
tending rural clinics versus receiving care from the referral hospital. From the marginal
distribution curve of dropout, we nd that the dropout rates are similar in the early
period (up to about 180 days) and then the dropout rate increases in the rural area
(Figure 2).
The conditional survival probabilities are seen to increase noticeably when subjects
are kept in care longer. In Figure 3, we see a similar increase in conditional survival
for both urban and rural clinics comparing dropout at 3 months with 6 months, or
comparing survival given retention in care > 3 months with > 6 months.
7 Discussion
In this article, we considered various estimation aspects and model selection for mor-
tality and dropout in the context of a large HIV care and treatment program in western
Kenya. We developed novel statistical methods in a semi-competing risk framework
where we were able to ascertain only a fraction of the terminal events. By utilizing
the correlation between the non-terminal and terminal events, we demonstrated that
improved estimation for the marginal and conditional distribution of the terminal event
is feasible as is the marginal distribution of the non-terminal event.
In addition to proving the asymptotic properties of the proposed estimators (Ap-
pendix), we performed simulations to assess their performance under scenarios closely
resembling the real-life settings where these methods will be applied. In all cases,
the performance of these estimators was excellent. This has a number of important
implications for the practical application of our methods. It means that program eval-
uation by assessment of HIV care and treatment program eectiveness metrics such
as mortality, patient retention, treatment interruption or disease progression rates, all
falling under our semi-competing risk framework, can be accomplished by locating only
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a relatively small subset of patients who are lost. This ensures the viability and sus-
tainability of ongoing program evaluation eorts in this setting as most programs in
low and middle-income countries in sub-Saharan Africa, Asia and Latin America are
so large and the loss to follow-up problem so pronounced (Rosen, Fox, and Gill 2007)
as to make it infeasible to follow-up all patients who discontinue treatment.
Our re-analysis of the AMPATH data (An, et al., 2008, Yiannoutsos, et al., 2008)
showed the advantages of being able to estimate conditional survival distributions for
the terminal event conditional on loss-to-follow-up (the non-terminal event). We con-
sidered three and six months, two important landmarks from start of therapy, when the
hazard of mortality is highest (Yiannoutsos, 2009). Conditioning on being retained on
treatment (and thus being alive) at 3 and 6 months after therapy produced estimates
of mortality (Figure 3 right panel), which were much lower than overall (marginal)
mortality (Figure 2 right panel). In addition, patient retention for at least six months
is associated with substantial improvement of mortality (both early and late) compared
to retention at least for three months (Figure 3). These results have important policy
implications about interventions which target patients early after initiating antiretro-
viral therapy. AMPATH for example, has instituted an intense follow-up of patients
during the rst three months after treatment initiation. These analyses provide strong
supportive evidence for such interventions.
While these analyses are intended more as a proof of concept rather than an ex-
haustive analysis of all possible explanatory factors of dropout and mortality patterns
in our setting, these rst results underline some important issues and further empha-
size the practical utility of these methods. The ability to explicitly model the possible
correlation between X and Y allows both the assessment of the strength of the associ-
ation as well as the comparison of these quantities between groups. In our re-analysis
of the AMPATH data, we see a possibly dierent pattern in the urban versus the rural
settings with dropout being associated less strongly with mortality in the rural setting.
These observations are important because they underscore the necessity of methods
which do not rely on independence assumptions between X and Y and the absolute
critical nature of outreach and vital status ascertainment among lost patients. In ad-
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dition, these ndings could be used to tailor contextually appropriate interventions
depending on the setting (rural versus urban).
While our motivating example was focused on issues arising in the evaluation of
large care and treatment programs recently proliferating in low and middle-income
countries, the applicability of the proposed methods is quite broad. The extent of
the application of this methodology is related both to the number of issues in this
context as well as any other chronic disease intervention requiring patient retention
and long-term adherence to treatment or prevention interventions.
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Appendix
We show the consistency and asymptotic distribution of ^, the estimator of the depen-
dency between X and Y in the context of semi-competing risks with incomplete vital
status ascertainment. Assume that the outreach probability p > 0, then similar to the
arguments in the web appendix of Lakhal et al. (2008), for any  > 0, all comparable
pairs belong to a bounded set S0 = f(x; y) : 0 > y  x > 0g with a high probability
1 22, where 0 is a xed number such that 0 < FX(0)G(0) < ; 0 < FY (0)G(0) < ,
and 0 < F (0; 0)G(0). Then because G^(y), P^
;2 are consistent estimators of their limit
in the set S0, F^
(x; y) is consistent for F (x; y) in S0. This leads to the consistency of ^

because (6) converges to its limit and is monotonic as a function of  for Archimedean
copulae.
For the asymptotic distribution, consider a Taylor expansion of the function (v) =
f1 + (v)g 1(v). The estimating function 	n() is asymptotically equivalent to
	n() '

n
2
 1X
i<j
W ( ~Sij; ~Rij)Zij
h
ij   f( ~Xij; ~Yij)g
 0f( ~Xij; ~Yij)gf^( ~Xij; ~Yij)  ( ~Xij; ~Yij)g
i
Because
^(x; y)  (x; y) = n 1G^(y) 1
nX
k=1
1(Sk > x;Rk > y) G(y) 1P (Sk > x;Rk > y)
= n 1fG^(y) 1  G(y) 1g
nX
k=1
1(Sk > x;Rk > y)
+n 1G(y) 1
nX
k=1
f1(Sk > x;Rk > y)  P (Sk > x;Rk > y)g
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we can break 	n() into two parts 	() = A+B where,
A =  

n
2
 1X
i<j
W ( ~Sij; ~Rij)Zij
h
0f( ~Xij; ~Yij)gn 1fG^( ~Yij) 1  G( ~Yij) 1g

nX
k=1
1(Sk > ~Xij; Rk > ~Yij)
i
=  

n
2
 1
n 1
nX
k=1
X
i<j
W ( ~Sij; ~Rij)Zij
0
f( ~Xij; ~Yij)gfG^( ~Yij) 1  G( ~Yij) 1g
1(Sk > ~Xij; Rk > ~Yij)
and
B =

n
2
 1X
i<j
W ( ~Sij; ~Rij)Zij
h
ij   f( ~Xij; ~Yij)g
 0f( ~Xij; ~Yij)gn 1G( ~Yij) 1
nX
k=1
f1(Sk > ~Xij; Rk > ~Yij)  P (Sk > ~Xij; Rk > ~Yij)g
i
=

n
2
 1
n 1
nX
k=1
X
i<j
W ( ~Sij; ~Rij)Zij
h
ij   f( ~Xij; ~Yij)g
 0f( ~Xij; ~Yij)gfG(y) 11(Sk > ~Xij; Rk > ~Yij)  ( ~Xij; ~Yij)g
i
:
The rst part is asymptotically equivalent to
A '  

n
2
 1X
i<j
W ( ~Sij; ~Rij)Zij
0
f( ~Xij; ~Yij)gfG^ 1( ~Yij) G 1( ~Yij)g( ~Xij; ~Yij)=G( ~Yij)
because fG^ 1( ~Yij)   G 1( ~Yij)g can be written as an iid random sum (Gill 1980 p37).
The second part is asymptotically equivalent to
B '  

n
2
 1
1
n
nX
k=1
X
i<j
W ( ~Sij; ~Rij)Zij
n1(Ck  t)(1 ZXk)
SZ(Ck )  G(
~Yij)
o
0f( ~Xij; ~Yij)g
( ~Xij; ~Yij)
G( ~Yij)
This is a U-statistic with order 3. Asymptotic normality then directly follows from the
theory of U-statistics.
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Table 1: Simulation results for the estimation of 
 = 2  = 3  = 4
Clayton; n = 1000
Mean Est 2.058 3.038 4.117
SE .411 .536 .658
Emp SE .410 .509 .660
95% CP 94.0 96.0 94.5
Clayton; n = 3000
Mean Est 1.993 3.035 4.011
SE .228 .298 .363
Emp SE .237 .290 .354
95% CP 92.8 95.2 96.8
Gumbel; n = 1000
Mean Est 2.023 2.935 4.001
SE .237 .407 .605
Emp SE .259 .418 .619
95% CP 91.8 92.8 93.2
Gumbel; n = 3000
Mean Est 2.077 2.972 3.965
SE .135 .234 .335
Emp SE .135 .251 .328
95% CP 92.8 92.5 93.2
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Table 2: Simulation results for the estimation of marginal distributions at times t = 1
(FX) and t = 2 (FY ). The target quantities are FX(1) = exp( 1) = 0:368 and
FY (2) = exp( 0:8 2) = 0:202.
 = 2  = 3  = 4
F^X F^
;1
Y F^
;2
Y F^
;M
Y F^X F^
;1
Y F^
;2
Y F^
;M
Y F^X F^
;1
Y F^
;2
Y F^
;M
Y
Clayton; n = 1000
Mean Est .368 .204 .205 .203 .369 .206 .209 .205 .368 .206 .208 .206
SE .021 .030 .029 .028 .020 .030 .029 .027 .018 .030 .030 .026
Emp SE .021 .032 .030 .029 .019 .033 .031 .029 .018 .030 .029 .026
95% CP 95.5 93.5 93.5 93.5 96.0 91.8 92.2 91.8 95.0 95.2 94.2 96.0
Clayton; n = 3000
Mean Est .368 .204 .205 .204 .368 .203 .205 .203 .368 .203 .205 .203
SE .012 .018 .017 .016 .011 .018 .017 .016 .011 .018 .017 .016
Emp SE .012 .018 .018 .016 .011 .019 .017 .017 .011 .019 .017 .017
95% CP 94.5 96.0 93.8 95.5 92.8 93.2 95.5 92.8 92.8 93.2 95.5 92.8
Gumbel; n = 1000
Mean Est .372 .208 .209 .208 .372 .205 .206 .206 .369 .208 .209 .207
SE .021 .032 .030 .031 .019 .031 .029 .029 .018 .031 .030 .028
Emp SE .022 .034 .032 .033 .018 .032 .032 .030 .019 .031 .031 .028
95% CP 93.0 92.0 91.8 93.8 96.8 93.5 92.5 93.5 91.5 93.2 93.0 93.8
Gumbel; n = 3000
Mean Est .370 .204 .204 .204 .370 .203 .202 .202 .370 .203 .202 .202
SE .012 .019 .018 .018 .011 .018 .017 .017 .011 .018 .017 .017
Emp SE .013 .020 .019 .020 .011 .019 .017 .017 .011 .019 .017 .017
95% CP 93.0 93.0 93.8 94.0 93.0 93.8 95.5 94.0 93.0 93.8 95.5 94.0
22
Table 3: Simulation results for the estimation of the conditional distributions.
 = 2  = 3  = 4
F^1:5j:75 F^1:5j:75+ F^1:5j:75 F^1:5j:75+ F^1:5j:75 F^1:5j:75+
Clayton; n = 1000
Mean Est .207 .587 .127 .585 .072 .576
SE .070 .062 .063 .065 .051 .068
Emp SE .074 .066 .065 .070 .048 .069
95% CP 92.0 92.0 94.8 90.2 95.0 92.2
Clayton; n = 3000
Mean Est .207 .588 .116 .581 .064 .569
SE .041 .036 .035 .039 .026 .041
Emp SE .044 .038 .034 .038 .028 .044
95% CP 92.0 93.0 94.2 93.5 94.0 92.2
Gumbel; n = 1000
Mean Est .363 .533 .246 .545 .162 .556
SE .067 .060 .064 .062 .058 .065
Emp SE .069 .066 .067 .067 .058 .068
95% CP 93.5 90.5 91.5 91.5 95.0 92.8
Gumbel; n = 3000
Mean Est .355 .526 .233 .540 .150 .545
SE .040 .036 .038 .038 .032 .039
Emp SE .043 .039 .039 .038 .032 .040
95% CP 93.0 94.0 94.8 95.5 95.0 94.5
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Table 4: Correct model selection percentage results based on 400 simulated data sets.
 = 2  = 3  = 4
n = 1000
Clayton 96 95 81
Gumbel 93 98 98
n = 3000
Clayton 100 99 89
Gumbel 100 100 100
Table 5: Data analysis results for the AMPATH study.
Urban Rural P-value
Estimand Est SE Est SE (Urban vs. Rural)
 2.865 .481 1.852 .419 .029
P (X > 1yr) .624 .007 .598 .013 .004
P (Y > 1yr) .915 .014 .892 .024 .183
P (Y > 1yrjX = 3mo; Y > 3mo) .864 .018 .846 .028 .395
P (Y > 1yrjX > 3mo; Y > 3mo) .958 .006 .941 .010 .020
P (Y > 1yrjX = 6mo; Y > 6mo) .949 .014 .930 .021 .240
P (Y > 1yrjX > 6mo; Y > 6mo) .985 .004 .974 .008 .041
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Figure 1: Eciency comparison for marginal survival estimation
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Figure 2: Marginal distribution estimation
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Figure 3: Conditional distribution estimation
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